MKP-5 Relieves Lipotoxicity-Induced Islet β-Cell Dysfunction and Apoptosis via Regulation of Autophagy

Area of Science:

• Cell Biology
• Metabolism
• Endocrinology

Background:

• Obesity and high-fat diets (HFD) impair pancreatic islet cell function.
• Lipid metabolism dysregulation contributes to islet cell dysfunction and apoptosis.
• Mitogen-activated protein kinase phosphatase-5 (MKP-5) is implicated in extracellular signaling and lipid metabolism.

Purpose of the Study:

• To investigate the role of MKP-5 in protecting pancreatic islet cells against lipotoxicity.
• To determine if MKP-5 modulates autophagy and apoptosis in response to lipotoxic conditions.
• To explore the therapeutic potential of MKP-5 in HFD-induced islet cell damage.

Main Methods:

• Assessing MKP-5 expression in pancreatic islet cells from HFD-fed mice.
• Utilizing palmitic acid (PA) to induce lipotoxicity in islet β-cells (Rin-m5f).
• Overexpressing MKP-5 using recombinant adenovirus (Ad-MKP-5) in islet cells.
• Employing autophagy inhibitor 3-methyladenine (3-MA) and MAPK pathway inhibitors (JNK, P38, ERK).

Main Results:

• HFD decreased MKP-5 expression in pancreatic islet cells.
• MKP-5 overexpression protected islet cells from PA-induced apoptosis, dysfunction, and autophagy inhibition.
• Lack of MKP-5 aggravated lipotoxicity.
• Ad-MKP-5 alleviated HFD-induced apoptosis and restored autophagic flux in mouse islet cells.
• MKP-5-mediated protection involved the enhancement of autophagic signaling and modulation of JNK and P38 MAPK pathways.

Conclusions:

• MKP-5 plays a crucial protective role against lipotoxicity in pancreatic islet cells.
• MKP-5 enhances autophagy and suppresses apoptosis, dysfunction, inflammation, and oxidative stress induced by lipotoxicity.
• Modulating MKP-5 expression, particularly through JNK and P38 pathways, offers a potential therapeutic strategy for managing HFD-induced islet cell damage.